Pharmacotherapy for Cardiovascular Disorders 6521
Case study: Patient AO has a history of obesity and has recently gained 9 pounds. The patient has been diagnosed with hypertension and hyperlipidemia. Drugs currently prescribed include the following:Atenolol 12.5 mg dailyDoxazosin 8 mg dailyHydralazine 10 mg qidSertraline 25 mg dailySimvastatin 80 mg dailySelect one the following factors: genetics, gender, ethnicity, age, or behavior factors.Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.Write a 2- to 3-page paper that addresses the following:Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.